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MacrophagesWe investigated the possibility that a cholesterol-rich milieu can accelerate response to pathogen-associated
molecular patterns in order to elucidate mechanisms underlying aggravation of atherosclerosis after bacterial
infection. The consumption of a high-cholesterol diet resulted in enhanced the expression of CD14 in arteries
of ApoE−/−mice. 27-Hydroxycholesterol (27OHChol), the most abundant cholesterol oxide in atherosclerotic
lesions, induced the signiﬁcant expression of CD14 by THP-1monocytic cells, but not by vascular smoothmuscle
cells or Jurkat T cells. Additions of lipopolysaccharide (LPS) to 27OHChol-treated THP-1 monocytic cells resulted
in superinduction in terms of the gene transcription of CCL2 and the secretion of its gene product. In contrast,
cholesterol did not cause increased the expression of CD14 in the aforementioned cells, and the addition of LPS
to cholesterol-treated monocytic cells did not result in enhanced the expression of CCL2. The conditioned
medium isolated from THP-1 cells exposed to 27OHChol plus LPS further induced the migration of monocytic
cells in comparison with conditioned media obtained from THP-1 cells treated with 27OHChol or LPS alone.
Treatment with 27OHChol also resulted in the enhanced secretion of MMP-9 and soluble CD14 (sCD14), and
the secretion of sCD14 was blocked by a selective MMP-9 inhibitor. The inhibition of the ERK pathway resulted
in signiﬁcantly attenuated the secretion of sCD14 via mechanisms that were distinct from those by PI3K
inhibition. We propose that 27OHChol can prime monocytes/macrophages by up-regulation of CD14 such that
LPS-mediated inﬂammatory reaction is accelerated, thereby contributing to aggravated development of
atherosclerotic lesions by enhancing recruitment of monocytic cells after infection with Gram-negative bacteria.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Atherosclerosis is initiated and promoted by an inﬂammatory
process considered to be caused by accumulation and oxidative modiﬁ-
cation of cholesterol in the artery [1]. Of the oxidative-modiﬁed cho-
lesterol derivatives, 27-hydroxycholesterol (27OHChol) is the most
abundantly detected form of cholesterol oxide in atherosclerotic
plaques from different sites [2,3]. During the early stage of atheros-
clerosis, circulating leukocytes, largely monocytes and T lymphocytes,
bind to cell adhesion molecules expressed on endothelial cells and
migrate into the intima, and migrated leukocytes further amplify the
inﬂammatory responses [1,4], which is directed by chemokines.
Among chemokines, the activity of chemokine (C-C motif) ligand 2inase; HAoSMCs, Human aortic
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usan.ac.kr (C.-D. Kim),(CCL2) directs themigration of monocytes to the atherosclerotic lesions
[5,6]. Therefore, understanding of the roles of oxidative-modiﬁed cho-
lesterol derivatives in CCL2 expression is critical as its activity is closely
linked to severity of atherosclerosis.
A large number of different infectious agents, includingMycoplasma
pneumonia,Chlamydia pneumoniae, Porphyromonas gingivalis, Helicobacter
pylori, Streptococcus spp., inﬂuenza A virus, hepatitis C virus (HCV), cy-
tomegalovirus (CMV), and herpes simplex virus (HSP), have been
found in atherosclerotic plaques [7]. The infectious burden is considered
to contribute to the pathogenesis of atherosclerosis. The development
of atherosclerotic lesions is accelerated in mice fed with high-
cholesterol diet infected with Gram-negative bacteria such as
C. pneumoniae and P. gingivalis or with Gram-positive bacteria like
Streptococcus mutans [8–10]. Acceleration can be due to direct effects
of the bacteria on vascular cells, including promotion of endothelial
dysfunction and activation of T lymphocytes and monocytes/macro-
phages [11]. The direct effects explain the roles of infecting bacteria
in inﬂammation in the vasculature. However, we propose that the
underlying mechanisms for development of aggravated atheroscle-
rotic lesions after bacterial infection should be understood in the
context of hypercholesterolemia because atherosclerosis requires
cholesterol in abundance in its pathogenesis.
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within a class of microbes referred to as pathogen-associatedmolecular
patterns (PAMPs), which are recognized by pattern recognition recep-
tors (PRRs) in infected organisms [12]. Lipopolysaccharide (LPS) is the
prototype PAMP derived from Gram-negative bacteria. LPS released
after infection is recognized by CD14, a PPR expressed by monocytes/
macrophages. CD14 binds to LPS and transfers the bound LPS to Toll-
like receptor 4 (TLR4), which initiates inﬂammatory responses bymedi-
ating the expression of chemokines like CCL2 [13]. CD14 plays a pivotal
in initiating responses to LPS. Macrophages and animals deﬁcient in
CD14 show markedly reduced sensitivity to LPS and no symptoms of
septic shock after exposure to LPS or Gram-negative bacteria, respec-
tively [14,15]. Therefore, the increased expression of CD14 in macro-
phages within atherosclerotic lesions [16] suggests that inﬂammatory
reaction against bacterial PAMPs can be enhanced in atherosclerosis.
In the current study, we determined the probability that cell homeo-
stasis is modiﬁed by the lipids present within atherosclerotic lesions
such that inﬂammatory reaction against infecting bacteria or bacterial
PAMPs is accelerated in atherosclerosis. We attempted to determine
whether cholesterol or its oxidized form present in atherosclerotic le-
sions can affect the expression of CD14 and inﬂammatory response to
LPS. We demonstrated for the ﬁrst time that 27OHChol induces the
up-regulated expression of CD14 in monocytic cells and predisposes
them to superinduction of CCL2 expression in response to LPS. We
also sought to elucidatemolecularmechanisms for the up-regulated ex-
pression of CD14 induced by 27OHChol.
2. Materials and methods
2.1. Animal experiments
Animal experiments were performed in accordancewith the Korean
Food and Drug Administration (KFDA) guidelines as previously de-
scribed [17]. Experimental protocols were approved by the Pusan Na-
tional University Animal Care and Use Committee.
2.2. Cells
THP-1 cells and Jurkat T cells were purchased from the American
Type Culture Collection (ATCC, Manassas, VA, USA). THP-1 cells and
Jurkat cells were maintained in RPMI 1640 supplemented with 10%
fetal bovine serum (FBS), penicillin (50 units/ml), and streptomycin
(50 μg/ml) in a humidiﬁed atmosphere of 5% CO2. Human aortic smooth
muscle cells (HAoSMCs) purchased from Cambrex (East Rutherford, NJ,
USA) were grown in Dulbecco's modiﬁed Eagle's medium (high glu-
cose) supplemented with 15% FBS and the antibiotics.
2.3. Reagents
Cholesterol and 27OHChol were purchased from Research Plus, Inc.
(Barnegat, NJ, USA). Lipopolysaccharide (LPS) was purchased from
InvivoGen (San Diego, CA, USA). LY294002 was purchased from
Sigma-Aldrich (St. Louis,MO, USA). U0126was purchased fromCell Sig-
naling Technology (Danvers, MA, USA). Oxidized LDL (oxLDL) was pur-
chased fromBiomedical Technologies Inc. (WardHill,MA, USA).MMP-9
inhibitor I was purchased from Calbiochem (San Diego, CA, USA).
2.4. Reverse transcription (RT) – real-time polymerase chain
reaction (PCR)
Total RNA was reverse-transcribed for 1 h at 42 °C with Moloney
murine leukemia virus reverse transcriptase, followed by polymerase
chain reaction (PCR) and real-time PCR using primers. The primers
were mouse GAPDH: 5′-acacattgggggtaggaaca-3′ (forward) and 5′-
aactttggcattgtggaagg-3′ (reverse); mouse CD14: 5′-ctgatctcagccctctgtcc-
3′ (forward) and 5′-gtcccagcccagtgaaagac-3′ (reverse); human GAPDH:5′-gagtcaacggatttggtcct-3′ (forward) and 5′-tgtggtcatgagtccttcca-
3′ (reverse); human CD14: 5′-aggcctcaaggtactgagca-3′ (forward)
and 5′-ctgttgcagctgagatcgag-3′ (reverse); human MMP-9: 5′-
ttcatcttccaaggccaatc-3′ (forward) and 5′-gccattcacgtcgtccttat-3′
(reverse); and human CCL2: 5′-tctgtgcctgctgctcatag-3′ (forward)
and 5′-cagatctccttggccacaat-3′ (reverse). Please see the supple-
mentary data for more details.
2.5. Flow cytometric analysis
THP-1 cells were harvested by centrifugation and incubated for
40 min with anti-CD14 antibody conjugated with ﬂuorescent dye
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 4 °C. After wash-
ing twice with PBS, cells were resuspended in 1% paraformaldehyde
in phosphate-buffered saline (PBS). Fluorescence was analyzed by
ﬂow cytometry.
2.6. Enzyme-linked immunosorbent assay
The levels of CCL2, sCD14, and MMP-9 secreted into the culture
media were determined using commercially available enzyme-linked
immunosorbent assay (ELISA) kits according to the manufacturer's
instructions (R&D Systems, Minneapolis, MN, USA).
2.7. Chemotaxis assay
The migration of THP-1 cells was measured using Transwell Perme-
able Supports (Costar, Cambridge, MA, USA) as previously described
[18].
2.8. MMP-9 gelatinolytic activity in cell supernatants
MMP-9 activity in cell supernatants was measured by zymography
using 8% polyacrylamide–SDS gels containing 0.2% type A gelatin
(Sigma-Aldrich). Please see the supplementary data for more
details.
2.9. Western blot analysis
CD14 and TLR4 proteinswere detected byWestern blot analysis. The
intensity of each immunoblot band was determined by using digitizing
software Un-Scan-It Gel (Silk Scientiﬁc Inc., Orem, UT). Please see the
supplementary data for more details.
2.10. Statistical analysis
Statistical analysis by Student's T test or one-way ANOVA
followed by Dunnett's multiple comparison test was performed
using PRISM (version 5.0) (GraphPad Software Inc., San Diego, CA,
USA). A P-value less than 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Elevated CD14 expression in the aortas of an animal
model of atherosclerosis
Because infectionwith Gram-negative bacteria resulted in accelerat-
ed atherosclerosis in an animal model of atherosclerosis [8,10], we
attempted to determine whether the expression of CD14, which initi-
ates response to LPS of bacteria, was changed in atherosclerotic arteries.
We compared the transcription of the CD14 gene between ApoE−/−
mice and wild-type mice fed a high-cholesterol diet. CD14 transcripts
were detected in six aortas out of six wild-type mice, and its transcrip-
tionwas enhanced in ApoE−/−mice (Supplementary Fig. 1). In compar-
ison with C57BL/6 wild-type mice, signiﬁcantly elevated levels of CD14
Fig. 1. Increased expression of the CD14 in a cholesterol oxide-rich milieu. (A) The levels of CD14 transcripts were assessed by real-time PCR using total RNA extracted from the aortas of
wild-type C57BL/6mice and ApoE−/−mice after a high-cholesterol diet for 12weeks. The y-axis values represent fold increases of CD14mRNA levels normalized to GAPDH levels relative
to those of the C57BL/6 mice. Data are expressed as mean ± SE (n= 6 individual mice for each group). **P b 0.01 vs. C57BL/6. (B) THP-1 cells, Jurkat T cells, and HAoSMCs were serum
starved for 24 h and incubated for 48 h in the absence or presence of cholesterol (5 μg/ml) or 27OHChol (2.5 μg/ml). Total RNA was isolated from the cells, and CD14 transcripts were
ampliﬁed by RT-PCR. (C) THP-1 cells (2.5 × 106 cells/100mm culture dish) were serum starved for 24 h in 10ml RPMI 1640 containing 0.1% BSA (endotoxin free), followed by incubation
with 27OHChol (2.5 μg/ml) for the indicated time periods. The levels of CD14 transcripts were assessed by real-time PCR. The y-axis values represent fold increases of CD14mRNA levels
normalized to GAPDH levels relative to those of THP-1 cells incubated inmedium alone (0 h). Data are expressed asmean± SD (n=3 replicates for each group). ***P b 0.001 vs. control.
(D) THP-1 cells, Jurkat T cells, and HAoSMCs were serum starved for 24 h and incubated for 48 h in the absence or presence of 27OHChol (2.5 μg/ml). CD14 protein was detected by
Western blot analysis.
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(Fig. 1A). In addition,ﬂuorescence immunostaining showed that the im-
munoreactivity of CD14was also enhanced in atherosclerotic lesions, as
examined using aortic roots of ApoE−/− and wild-type mice (Supple-
mentary Fig. 2). These results indicate up-regulation of CD14 in the ar-
teries of ApoE−/−mice.3.2. Up-regulated expression of CD14 in monocytic cells by 27OHChol
We attempted to determine the lipids responsible for the expres-
sion of CD14 in the atherosclerotic artery. Because cholesterol and
27OHChol are the two most abundant lipids in atherosclerotic le-
sions, we attempted to determine whether they had an effect on levels
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cells were treatedwith cholesterol and 27OHChol, prior to examination
of CD14 (Fig. 1B). CD14 transcripts were weakly detected from THP-1
cells, HAoSMCs, and Jurkat T cells, and themarkedly elevated transcrip-
tion of CD14 was observed in THP-1 cells in the presence of 27OHChol
(Fig. 1C). However, a higher concentration of cholesterol did not affect
CD14 expression in the three types of cells (Fig. 1B). We investigated
whether 27OHChol inﬂuenced the expression of CD14 protein. Treat-
ment with 27OHChol led to increased level of CD14 protein mainly in
THP-1 cells in comparison with Jurkat cells or HAoSMCs (Fig. 1D).
These results indicate that the oxidized form of cholesterol, rather
than cholesterol, induces the expression of CD14 in monocytic cells.3.3. Superproduction of CCL2 by monocytic cells in response to LPS in the
presence of 27OHChol
CD14 binds LPS, and LPS-CD14 complexes elicit production of
chemokines by the activation of monocytes and macrophages via TLR4
[19]. Since 27OHChol induced the up-regulated expression of CD14,
we attempted to determine whether response to LPS was inﬂuenced
by the presence of 27OHChol. THP-1 cells were treated with cholesterol
or 27OHChol, followed by addition of LPS, and the expression of CCL2
was then analyzed by real-time PCR and ELISA (Fig. 2). LPS induced
the transcription of CCL2 in THP-1 cells in a concentration-dependent
manner. The levels of CCL2 transcripts increased by 1.7-, 8.7-, and
19.5-fold in the presence of 1, 10, and 100 ng/ml of LPS, respectively,
in comparison with control. 27OHChol alone increased the level of
CCL2 transcripts by 8.3-fold. The addition of LPS to 27OHChol-treated
cells resulted in a further increase in induction of CCL2 transcription;
CCL2 transcriptswere elevated by 43.5-fold and 52.6-foldwith the addi-
tion of LPS at a ﬁnal concentration of 10 and 100 ng/ml to 27OHCHol-
treated cells, respectively (Fig. 2A. Please see Supplementary Fig. 3 for
RT-PCR). 27OHChol and LPS affected the secretion of CCL2 in a pattern
similar to those observed with the transcription of the gene. LPS en-
hanced CCL2 secretion in a concentration-dependent manner in THP-1
cells. 27OHChol also induced the secretion of CCL2, and the addition of
LPS to 27OHChol-treated cells resulted in further enhanced the secre-
tion of CCL2 (Fig. 2B). In contrast, the addition of LPS to THP-1 cells in-
cubated with cholesterol did not enhance induced the expression of
CCL2 (Supplementary Fig. 4).
We also investigated whether 27OHChol affected the expression of
TLR4 because LPS-CD14 complex induces inﬂammatory responses via
the receptor [19,20]. Treatment with 27OHChol or cholesterol did not
inﬂuence the expression of TLR4, as determined byRT-PCR andWestern
blot analysis (Supplementary Fig. 5).
In order to determine whether secreted CCL2 was functional, we
performed a chemotaxis assay, as previously described [18]. The signif-
icantmigration ofmonocytic cellswas induced in response to the super-
natant containing CCL2 which was isolated after stimulation of THP-1
cells with 27OHChol or LPS. The migration was further induced inFig. 2. Enhanced expression of CCL2 in response to LPS in the presence of 27OHChol. (A,
B) Serum-starved THP-1 cells were incubated for 24 h in the absence or presence of
27OHChol (2.5 μg/ml) and stimulated for 9 h with or without the indicated amount of
LPS. (A) The levels of CCL2 transcripts were assessed by real-time PCR. The y-axis values
represent fold increases of CCL2 mRNA levels normalized to GAPDH levels relative to
those of control THP-1 cells incubated in medium alone. Data are expressed as mean ±
SD (n = 3 replicates for each group). *P b 0.05 vs. control; ***P b 0.001 vs. control;
###P b 0.001 vs. 27OHChol; +++P b 0.001 vs. corresponding LPS. (B) The amount of
CCL2 secreted into culture media was measured by ELISA. Data are expressed as
mean ± SD (n = 3 replicates for each group). ***P b 0.001 vs. control; ###P b 0.001 vs.
27OHChol; +++P b 0.001 vs. corresponding LPS. (C)Monocytic cells were exposed to con-
ditioned media isolated from THP-1 cells treated with 27OHChol, LPS, or 27OHChol plus
LPS, as described above. Migration of monocytic cells in response to the conditioned
media was determined by chemotaxis assays. Data represent the mean ± SD of migrated
cells counted from three individual samples for each group. *P b 0.05 vs. control; **P b 0.01
vs. control; ***P b 0.001 vs. control; ##P b 0.01 vs. 27OHChol; ###P b 0.001 vs. LPS.
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cells with LPS in the presence of 27OHChol (Fig. 2C).
3.4. Enhanced secretion of sCD14 in the presence of 27OHChol
CD14 is found in two forms; a membrane-associated form (mCD14)
and a soluble form (sCD14) [21]. We attempted to determine whether
27OHChol affected release of CD14. THP-1 cells released a low amount
of soluble CD14 and the amount of released soluble CD14 was elevated
in proportion to duration of treatment with 27OHChol (Fig. 3A). The
amount of sCD14 detected in the media was 29.2 ± 10.5 pg/ml when
cells were not stimulated, and it increased to 76.8 ± 19.6 pg/ml,
270.5 ± l31.0 pg/ml, and 1035.4 ± 126.8 pg/ml after treatment with
27OHChol for 12 h, 24 h, and 48 h, respectively. Cell surface CD14
binds LPS and initiates response to LPS [21]. Because LPS response was
enhanced in the presence of 27OHChol, we attempted to determine
whether 27OHChol also inﬂuenced levels of CD14 protein on the sur-
face. Results of ﬂow cytometric analyses showed an increased level of
CD14 on the cell surface in the presence of 27OHChol. The percentage
of control THP-1 cells that expressed a high level of CD14 was 0.5%,
which increased to 13.8% in the presence of 27OHChol (Fig. 3B).
The formation of sCD14 can occur after cleavage ofmCD14 by prote-
ase likeMMP-9 [22]. Therefore,we investigated thequestion ofwhether
MMP-9 participated in 27OHChol-induced the secretion of sCD14. First,
we investigated the effects of 27OHChol on the expression of MMP-9.
We measured the expression of MMP-9 via quantitative assays. MMP-
9 expression was induced at 12 h after the treatment of monocytic
cells with 27OHChol and sustained up to 48 h after the treatment (Sup-
plementary Fig. 6). In accordancewith the real-time PCR data, the treat-
ment of monocytic cells with 27OHCHol resulted in signiﬁcantly
increased the secretion of MMP-9, as determined by ELISA, in propor-
tion to the duration of treatment (Fig. 3C). The activity of MMPs secret-
ed by THP-1 cells was analyzed by gelatin zymography using the
supernatant of smooth muscle cells as a positive control. Both MMP-2
as well as MMP-9 gelatinolytic activity was detected in the supernatant
of smooth muscle cells. The treatment of THP-1 cells with 27OHChol
resulted in increased MMP-9 activities in supernatants in a time-
dependent manner up to 48 h post-treatment (Fig. 3D). The addition
of MMP-9 inhibitor I, a cell permeable, selective, reversible inhibitor of
MMP-9, to 27OHCHol-treated monocytic cells resulted in signiﬁcantly
attenuated the secretion of sCD14 (Fig. 3E). TheMMP-9 inhibitor I, how-
ever, did not inﬂuence the expression of tumor necrosis factor-α (TNF-
α) or CD88 whose expression was reported to be induced in the pres-
ence of 27OHChol [18,23] (Supplementary Fig. 7). These results indicate
that MMP-9 is involved in 27OHChol-induced the secretion of sCD14
from monocytic cells.
For the investigation of the effects of oxLDL on CD14 expression,
THP-1 cells were treated with oxLDL in parallel with 27OHChol, and
the levels of CD14 transcripts and secretion of sCD14 were determined
by real-time PCR and ELISA, respectively (Fig. 3F and Supplementary
Fig. 8). 27OHChol induced the signiﬁcant transcription of the CD14
gene aswell as release of sCD14, as described above. OxLDL also affected
CD14 expression primarily at the protein level. OxLDL induced the slight
elevation of CD14 transcription by 1.8-fold but signiﬁcantly enhanced
sCD14 release, although to a lesser extent than 27OHChol, from THP-1
cells.
3.5. Differential regulation of CD14 expression by PI3K and ERK pathways
We previously reported that 27OHChol activated both
phosphoinositide-3-kinase (PI3K)/Akt and extracellular-signal-
regulated kinase (ERK) pathways [17]. Therefore, we investigated the
role of each signaling pathway in the expression of CD14 using pharma-
cological inhibitors. The inhibition of the ERK pathway using U0126
resulted in the attenuated transcription of CD14 (Fig. 4A) and near ab-
rogation of sCD14 secretion induced by 27OHChol (Fig. 4B). In themean time, LY294002, an inhibitor of the PI3K pathway, did not inﬂu-
ence the transcription of the CD14 gene (Fig. 4A) but signiﬁcantly
inhibited the secretion of sCD14 (Fig. 4B), which indicated that the
PI3K pathway regulated the secretion of sCD14. Therefore, we investi-
gated the effects of LY294002 on MMP-9 expression in parallel with
U0126. Both LY294002 and U0126 almost completely inhibited the
transcription of MMP-9 and secretion of its gene product induced by
27OHChol (Fig. 4C). The inhibition was not due to cytotoxicity of
the inhibitors because an addition of LY294002 or U0126 did not
reduce viability of 27OHchol-treated THP-1 cells (Supplementary
Fig. 9). Collectively, these results showed that LY294002 inhibited
the secretion of sCD14 by blocking MMP-9 expression rather than
by affecting the expression of the CD14 gene.
4. Discussion
ApoE−/− mice are a popular animal model for examining the
in vivo inﬂuence of cholesterol on gene expression in conjunction
with pathogenesis of atherosclerotic lesions. The consumption of a
high-cholesterol diet leads to atherosclerosis throughout the arterial
tree of ApoE−/− mice with accumulation of cholesterol, which un-
dergoes oxidative modiﬁcations [24–26]. Using this animal model,
we observed signiﬁcantly increased the transcription of the CD14
gene in the arteries of ApoE−/− mice in comparison with wild-type
mice after a high-cholesterol diet. These results indicate that a
high-cholesterol milieu is sufﬁcient for induction of CD14 expression
in the arteries.
Atherosclerotic lesions are heterogeneous not only in the cellular
composition but also in lipid composition. The most abundant lipid in
atherosclerotic lesions is cholesterol, followed by 27OHChol [24]. We
found that 27OHChol, but not cholesterol, induced the transcription of
CD14. The effect of 27OHChol appears to be cell-type speciﬁc because
up-regulation of CD14 occurred in macrophages, but not in vascular
smooth muscle cells (VSMCs) and T cells. These results are in line with
those of the previous study by Waldo et al. [16], who reported that
CD14-positive cells were predominantly macrophages within athero-
sclerotic lesions. Taken together, our results indicate that oxidative-
modiﬁed cholesterol derivatives, like 27OHChol, will induce the expres-
sion of CD14 in macrophages within atherosclerotic lesions.
We observed an exaggerated response of monocytic cells to LPS in
the presence of 27OHChol, as determined by CCL2 expression.
27OHChol and LPS appeared to synergistically induce CCL2 expres-
sion, as the levels of transcription as well as the secretion of CCL2 in-
duced by treatment with 27OHChol plus LPS weremuch greater than
summation of the levels observed with each treatment alone. These
results are in agreement with those of the previous report in that
CD14 binds LPS and activates cells by subsequent transfer of bound
LPS to TLR4 and that activated cells express various cytokines and
chemokines, including CCL2 [20,27–29]. Because CCL2 plays a
major roles in recruitment of monocytes into atherosclerotic lesions
[6,29], we investigated the chemotactic activity of the secreted CCL2.
The migration of THP-1 monocytic cells was also further induced in
response to conditioned media containing CCL2 secreted from
27OHChol-treated monocytic cells in response to LPS. Taken togeth-
er, our results indicate that 27OHChol induces up-regulation of
CD14, which will bring about an accelerated inﬂammatory response
to LPS in atherosclerotic lesions.
GPI-anchoredmCD14 is released by shedding in response to various
stimuli, probably mediated by proteases such as leukocyte elastase and
metalloproteinases [22,30]. Surfactant protein D has been reported to
increase sCD14 in a process mediated by MMP-9 and MMP-12 in
mouse macrophages [22]. We observed a substantial reduction in
27OHChol-induced the secretion of sCD14 by inhibition ofMMP-9, indi-
cating that 27OHChol can induce the secretion of sCD14 frommonocytic
cells via MMP-9-dependent shedding. CD14 can also be secreted as a
soluble molecule via different mechanisms [31]. CD14 molecules stored
Fig. 3. Effects of 27OHChol and oxLDL on production of sCD14. (A) Serum-starved THP-1 cells were incubatedwith 27OHChol (2.5 μg/ml) for the indicated time periods, and the amount of
sCD14 secreted into culturemediawasmeasuredby ELISA. Data are expressed asmean± SD (n=3 replicates for each group). ***P b 0.001 vs. control. (B) Serum-starved THP-1 cellswere
incubated in the absence or presence of 27OHChol, followed by immunostaining of THP-1 cells for cell surface CD14. Flow cytometry was performed for analysis of ﬂuorescence.
(C) Serum-starved THP-1 cells were incubated with 27OHChol (2.5 μg/ml) for the indicated time periods, and the amount of total MMP-9 (pro- and active) secreted into culture media
was measured by ELISA. Data are expressed as mean ± SD (n = 3 replicates for each group). ***P b 0.001 vs. control. (D) Serum-starved THP-1 cells were incubated with 27OHChol
(2.5 μg/ml) for the indicated time periods. The activity of MMP-9 secreted by the cells was assessed by zymography. Control THP-1 cells were incubated for 48 h in medium alone, and
rat AoSMCswere treatedwith platelet-derived growth factor (5 ng/ml) for 12 h. (E) Serum-starved THP-1 cells were incubated for 24 h in the absence or presence of 27OHChol, followed
by incubation for 24 h with or without MMP-9 inhibitor I (10 nM). The amount of sCD14 secreted into culture media was measured by ELISA. Data are expressed as mean ± SD (n= 3
replicates for each group). ***P b 0.001 vs. control. ##P b 0.01 vs. 27OHChol. ###P b 0.001 vs. 27OHChol. (F) Serum-starved THP-1 cells were incubatedwith 27OHChol (2.5 μg/ml) or oxLDL
(50 μg/ml) for 48 h, and the amount of sCD14 secreted into culturemediawasmeasured by ELISA. Data are expressed asmean± SD (n=3 replicates for each group). *P b 0.05 vs. control.
***P b 0.001 vs. control.
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with the C-terminal leader sequence [31]. Therefore, the possibility
that 27OHChol might inﬂuence direct secretion from intracellular vesi-
cles should not be excluded.
We attempted to identify signaling pathways involved in CD14 pro-
duction induced by 27OHChol. PI3K and ERK pathways were selectedbecause involvement of both signaling pathways in action of 27OHChol
as well as oxysterol mixture has been reported [17,18,32]. We found
that the ERK and PI3K signaling pathways have both common and dis-
tinct roles in 27OHChol-induced up-regulation of CD14. The PI3K path-
way is required for the secretion of sCD14, and the ERK pathway is
required for the transcription of CD14 as well as the secretion of
Fig. 4. Effects of inhibitors of the PI3K and ERK pathways on the expression of CD14 and MMP-9. (A–C) Serum-starved THP-1 cells were treated with 27OHChol for 48 h after pre-
incubation for 2 h in the absence or presence of the indicated inhibitors (10 μM each). (A) CD14 transcripts were ampliﬁed by RT-PCR (upper panel), and the levels of CD14 transcripts
were assessed by real-time PCR. The y-axis values represent fold increases of CD14 mRNA levels normalized to GAPDH levels relative to those of control THP-1 cells incubated in culture
medium alone. (lower panel). Data are expressed as mean ± SD (n=3 replicates for each group). ***P b 0.001 vs. control; ###P b 0.001 vs. 27OHChol. (B) The amount of sCD14 secreted
into culture mediawasmeasured by ELISA. Data are expressed asmean± SD (n=3 replicates for each group). ***P b 0.001 vs. control. ###P b 0.001 vs. 27OHChol. (C) MMP-9 transcripts
were ampliﬁed by RT-PCR (upper panel), and the bands on agarose gels were quantiﬁed by using Un-Scan-It Gel (middle panel). The amount of MMP-9 secreted into medium was
measured by ELISA (lower panel). Data are expressed as mean ± SD (n= 3 replicates for each group). ***P b 0.001 vs. control. ###P b 0.001 vs. 27OHChol.
448 S.-M. Kim et al. / Biochimica et Biophysica Acta 1852 (2015) 442–450sCD14. These results suggest a major role ERK pathway in enhanced the
transcription of CD14 and a complex control of sCD14 secretion in the
presence of 27OHChol. The current study, however, did not attempt to
determine whether PI3K and ERK acted in an independent or coopera-
tive manner. Additional study is necessary in order to elucidate the
types of connections or crosstalk that may be occurring between the
two pathways in the presence of 27OHChol.
Plaque oxysterols have been reported to induce the expression of
MMP-9 in promonocytic cells [18,32]. However, the underlying mecha-
nisms for the 27OHChol-induced expression of MMP-9 remain un-
known. In the current study, we provided molecular mechanisms for
induction of MMP-9 expression by 27OHChol in monocytic cells. We
found that the ERK pathway was required in 27OHChol-mediated pro-
duction of MMP-9, in linewith previous studies that reported participa-
tion of this pathway inMMP-9 expression induced by oxysterolmixture
and oxLDL [32,33]. In addition, we found that the extent of inhibition of
transcription and the secretion of MMP-9 by treatment with LY294002
was comparable to those observed byU0126. These results indicate thatthe PI3K pathway is also essential for induction of MMP-9 expression.
Collectively, our data indicate that both the ERK and PI3K pathways
should be active for induction of MMP-9 expression by 27OHChol,
thereby leading to sCD14 secretion, in monocytic cells.
OxLDL, a complex mixture of various components composed of
lipid hydroperoxide, aldehyde, and cholesterol oxides [34,35], exhibits
multiple effects. OxLDL stimulates the expression of intercellular adhe-
sion molecule-1 (ICAM-1) by human umbilical vein endothelial cells
(HUVEC) and increases leukocyte-endothelial cell adhesion [36,37].
Therefore, the oxidation of accumulated LDL has been suggested to pro-
mote inﬂammation. In the current study, we found a new effect of
oxLDL on vascular cells; it induced release of sCD14 from monocytic
cells. Of the two lipids examined, 27OHChol was more efﬁcient than
oxLDL in induction of sCD14 release. We think that this observation
may be a result of lipid composition of oxLDL. OxLDL used in this
study was Cu2+-oxidized LDL, which predominantly contains sterols
oxygenated in the 7-position in the order of 7-ketocholesterol, 7β-
hydroxycholesterol, and 7α-hydroxycholesterol, rather than 27OHChol
Fig. 5. Enhanced inﬂammatory response to LPS in the presence of 27OHCHol. (A) 27OHChol promotes the secretion of CCL2 andMMP-9 frommacrophages. Secreted CCL2 participates in
recruitment of monocytes and MMP-9 contributes to proteolytic shedding of CD14 whose expression was also up-regulated by 27OHChol. Therefore, exposure of macrophages to
27OHChol leads to a condition with elevated levels of mCD14 and sCD14 on and around macrophages, respectively. (B) The elevated levels of CD14 allow formation of more LPS-CD14
complexes and transfer of more LPS to TLR4, which further activates macrophages such that substantially high amounts of CCL2 are secreted, thereby enhancing migration of more
monocytes and aggravating inﬂammation in atherosclerotic lesions.
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oxLDL can also induce the secretion of sCD14. Currently, the question
of whether and how the aforementioned 7-oxygenate cholesterols in-
ﬂuence the secretion of sCD14 is under investigation.
CD14 is a pattern recognition receptor with broad ligand speciﬁcity.
In addition to LPS, CD14 recognizes diverse structures from invading
microbes, such as lipoteichoic acid (LTA) from Gram-positive bacteria
[38], lipoarabinomannan (LAM) frommycobacteria [39], and viral dou-
ble-stranded (ds) RNA [40]. Therefore, it is possible that the elevated ex-
pression of CD14 induced by 27OHChol may inﬂuence inﬂammatory
responses to diverse pathogens detected in atherosclerotic lesions.
Based on our results and previous ﬁndings, we propose a model for ac-
celerated inﬂammation by 27OHChol and LPS in atherosclerotic lesions
(Fig. 5). Macrophages exposed to 27OHChol secrete CCL2 and MMP-9
and show an elevated level of mCD14. CCL2 will direct the migration
of monocytes attached on endothelium which express cell adhesion
molecules induced by oxLDL, and MMP-9 will enhance the secretion
of sCD14 by conversion of mCD14 to sCD14 (Fig. 5A). Elevated levelsofmCD14 and sCD14 result in enhanced delivery of LPS to TLR4 after in-
fection with Gram-negative bacteria, resulting in superinduction of
CCL2 expression and enhanced migration of monocytes (Fig. 5B).
Since sCD14 induces responses of CD14-negative endothelial cells
as well as CD14-positive macrophages to LPS [27,41], secreted
sCD14 may induce activation of endothelial cells in response to
Gram-negative bacteria in the atherosclerotic lesions.
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